This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 11/15/2021
Location: Virtual
Subject: Health Policy, Accessibility, and COVID-19
FDA Participant/Group: SHANNON HATCH;
Non FDA Participant/Group: Members of the Harvard MEDLIFE Chapter and media

Event Date: 11/15/2021
Location: Virtual
Subject: What We've Learned from the COVID-19 Pandemic and How It Will Change the Way We Work
FDA Participant/Group: JOHN GOODRICH;
Non FDA Participant/Group: Government, industry, and other invited guests

Event Date: 11/16/2021
Location: Virtual
Subject: User Fees
FDA Participant/Group: JULIA TIERNEY;
Non FDA Participant/Group: Carlos Garner, David Ricks (Eli Lilly);

Event Date: 11/17/2021
Location: Virtual
Subject: Lausanne VIII: Building Global Momentum for Interventions in Alzheimer's Disease
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other invited guests

Event Date: 11/17/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines

Event Date: 11/18/2021
Location: Virtual
Subject: Closer to Zero Action Plan: Impacts of Toxic Element Exposure and Nutrition at Different Crucial Developmental Stages
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, and other registered guests

Event Date: 11/18/2021
Location: Virtual
Subject: Selection Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of Patient-Centered Outcomes Research Institute

Event Date: 11/19/2021
Location: Virtual
Subject: HEVER COVID-19 Follow-Up
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, and other invited guests

Event Date: 11/19/2021
Location: Virtual
Subject: Stanford Symposium Series - The Pandemic Puzzle: Lessons from COVID-19
FDA Participant/Group: ABIGAIL CAPOBIANCO;
Non FDA Participant/Group: Government, industry, academia, and other invited guests

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 11/16/2021
Location: Virtual
Subject: Dubai's 15th International Food Safety Conference 2021; Speaker: FDA's New Era of Smarter Food Safety Update
FDA Participant/Group: N/A
Non FDA Participant/Group: International regulatory officials, industry representatives, and academia

Event Date: 11/16/2021
Location: Virtual
Subject: Association of Food and Drug Officials Fall Board Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: State and federal regulatory officials, industry representatives, trade associations, academia, and consumer organizations

Event Date: 11/17/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: SHERA MOXLEY; RUTH WATSON;
Non FDA Participant/Group: Representative Jimmy Panetta (D-CA)

Event Date: 11/17/2021
Location: Virtual
Subject: Dietary Supplement Issues of Mutual Interest
FDA Participant/Group: DOUGLAS STEARN;
Non FDA Participant/Group: James Griffiths, Steve Mister (Council for Responsible Nutrition);

Event Date: 11/17/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: JEFFREY FARRAR;
Non FDA Participant/Group: Karen Ross, Natalie Krout (California Department of Food and Agriculture);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 11/15/2021
Location: Virtual
Subject: COVID-19 Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Centers for Medicare and Medicaid Services Office of Minority Health “COVID-19 Vaccine Webinar for Rural Communities”

Event Date: 11/16/2021
Location: Virtual
Subject: The Development of Biologic Products: Vaccines and Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Brigham and Women’s Hospital Hematology/Oncology Grand Rounds

Event Date: 11/18/2021
Location: Virtual
Subject: Voices from the Frontlines: Public Service and Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Alliance for Health Policy event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 11/17/2021
Location: Virtual
Subject: Use of Impella in Patients with Rare Metabolic Diseases
FDA Participant/Group: NICOLE IBRAHIM; NICOLE GILLETTE; MEIR SHINNAR; DANIEL CANOS; WILLIAM MAISEL; BRAM ZUCKERMAN; ANDREW FARB; REBECCA TORGUSON; CHANGFU WU;
Non FDA Participant/Group: Chuck Simonton, David Weber, Seth Bilazarian, Eric Rose, Michael Minogue (Abiomed); Gregg Stone (Cardiovascular Research Foundation)

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

Event Date: 11/16/2021
Location: Virtual
Subject: Tobacco Merchants Association 2021 Digital Conference; Speaker: Keynote Address - Update from FDA’s Center for Tobacco Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Tobacco Merchants Association

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event